# Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

> **NCT00179517** · PHASE2 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Seizure Disorder
- Hypogonadism
- Erectile Dysfunction

## Interventions

- **DRUG:** Anastrozole 1mg
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT00179517
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00179517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00179517, "Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00179517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*